問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taipei WanFang Hospital (Managed by Taipei Medical Univeristy)
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Dermatology
下載
2021-09-01 - 2026-12-31
Condition/Disease
Test Drug
Participate Sites5Sites
Recruiting5Sites
2021-09-01 - 2023-12-31
Recruiting1Sites
Terminated4Sites
2024-02-01 - 2028-03-01
Participate Sites7Sites
Recruiting7Sites
2020-05-20 - 2023-09-11
Participate Sites4Sites
Suspended4Sites
2023-02-01 - 2024-08-08
Participate Sites9Sites
Recruiting9Sites
2009-08-01 - 2012-12-31
Participate Sites6Sites
Terminated6Sites
2012-03-16 - 2013-03-16
2010-09-01 - 2011-08-31
Participate Sites2Sites
Terminated2Sites
2018-12-13 - 2020-12-09
Moderate to Severe Atopic Dermatitis
ABT-494 (Upadacitinib)
2010-01-01 - 2012-12-31
全部
